AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,543 | +85.0% | 62,360 | +112.4% | 0.01% | +100.0% |
Q2 2023 | $834 | +23.6% | 29,360 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $675 | -22.0% | 29,360 | -4.6% | 0.01% | -28.6% |
Q4 2022 | $865 | -99.9% | 30,763 | -5.5% | 0.01% | 0.0% |
Q3 2022 | $920,000 | +27.6% | 32,545 | 0.0% | 0.01% | +40.0% |
Q2 2022 | $721,000 | -23.7% | 32,545 | 0.0% | 0.01% | -16.7% |
Q1 2022 | $945,000 | -13.4% | 32,545 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $1,091,000 | -27.4% | 32,545 | 0.0% | 0.01% | -25.0% |
Q3 2021 | $1,502,000 | -16.2% | 32,545 | 0.0% | 0.01% | -27.3% |
Q2 2021 | $1,793,000 | +6.9% | 32,545 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $1,677,000 | – | 32,545 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |